Combination of calcitriol and dietary soy exhibits enhanced anticancer activity and increased hypercalcemic toxicity in a mouse xenograft model of prostate cancer.

Abstract

BACKGROUND:

The potential role of vitamin D and soy in prostate cancer (PCa) prevention/treatment has gained much attention in recent years. In this study, we evaluated the anticancer activity of calcitriol, the active form of vitamin D, dietary soy, and their combinations in a mouse model of PCa.

METHODS:

Athymic male nude mice bearing PC-3 human PCa xenografts received diets containing 10 or 20 kcal% soy, calcitriol injections, or a combination of dietary soy and calcitriol. Changes in tumor growth, serum levels of 1,25(OH)(2)D and calcium, and regulation of tumor gene expression were examined.

RESULTS:

The combination treatments resulted in substantially greater inhibition of tumor growth than either agent alone. Soy diets alone caused a modest elevation in serum 1,25(OH)(2)D, whereas the calcitriol-soy combinations led to substantially elevated serum 1,25(OH)(2) D, hypercalcemia, and in some cases lethal toxicity. The combinations enhanced calcitriol activity in regulating target gene expression, including greater up-regulation of anti-proliferative (p21, IGFBP-3) and pro-apoptotic (Bax) genes, increased inhibition of anti-apoptotic (Bcl-2) and cell cycle promoting (cyclin D1) genes, and suppression of prostaglandin (PG) synthesis and signaling (COX-2, 15-PGDH, PG receptors). Increases in serum calcium were accompanied by elevated expression of intestinal calcium absorption genes (TRPV6, calbindin-9k).

CONCLUSIONS:

Soy increases the bioavailability of endogenous and administered calcitriol, thereby enhancing its anticancer effects and risk of hypercalcemia. Since both agents are easily available as dietary supplements, the increased potential for hypercalcemic toxicity becomes an important factor when considering the combined use of vitamin D and soy in PCa therapy.

• Authors: Jennifer Y Wang, Srilatha Swami, Aruna V Krishnan, David Feldman
• Journal: The Prostate (Prostate) Vol. 72 Issue 15 Pg. 1628-37 (Nov 2012) ISSN: 1097-0045 [Electronic] United States
• PMID: 22457201 (Publication Type: Journal Article)
• Copyright: Copyright © 2012 Wiley Periodicals, Inc.

Chemical References

• Prostaglandins
• Soybean Proteins
• Vitamins
• Calcitriol

Topics

• Adenocarcinoma (drug therapy, pathology)
• Animals
• Antineoplastic Combined Chemotherapy Protocols
• Apoptosis (drug effects, genetics)
• Calcitriol (adverse effects, blood, therapeutic use)
• Cell Cycle (drug effects, genetics)
• Cell Proliferation (drug effects)
• Dietary Supplements
• Drug Therapy, Combination
• Gene Expression Regulation, Neoplastic (drug effects)
• Humans
• Hypercalcemia (chemically induced, pathology)
• Male
• Mice
• Mice, Nude
• Prostaglandins (biosynthesis)
• Prostatic Neoplasms (drug therapy, pathology)
• Signal Transduction (drug effects)
• Soybean Proteins (administration & dosage, adverse effects)
• Vitamins (adverse effects, therapeutic use)
• Xenograft Model Antitumor Assays